IntrinsicIntrinsic
← Scroll for more →

Financial Statements — EOCN

Balance Sheet

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents--3.993.314.964.651.842.861.012.021.982.887.92
Short-term Investments--7.038.188.107.185.947.537.5611.7720.4231.9341.33
Accounts Receivable--------0.67--0.48--0.83--1.13--
Total Current Assets--18.6319.7221.0816.1210.0813.249.7914.7223.1336.0551.67
Property, Plant & Equipment----------0.080.080.100.110.130.140.16
Total Non-current Assets*--0.001.861.862.383.273.393.491.840.450.550.66
Total Assets--18.6321.5822.9418.5013.3416.6313.2816.5623.5836.6052.33
Accounts Payable--2.001.671.371.311.201.882.142.562.094.875.63
Total Current Liabilities--2.852.472.422.171.552.752.723.092.735.887.01
Total Non-current Liabilities*--0.000.000.000.000.000.000.040.040.130.230.32
Total Liabilities*--2.852.472.422.171.552.752.723.142.866.117.33
Retained Earnings--(210.78)(205.96)(204.07)(200.47)(195.35)(192.95)(189.46)(186.04)(178.05)(168.17)(153.01)
Total Stockholder Equity13.9515.7819.1120.5216.3311.7913.8810.5513.4220.7130.5045.00
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Research & Development1.78--1.091.060.530.812.587.04
Selling, General & Admin0.99--1.011.050.691.061.151.38
Total Operating Expenses2.78--2.102.111.221.873.738.41
Net Income(2.72)(1.91)(1.89)(2.49)(1.12)(1.59)(3.73)(8.40)
Basic EPS2.86--0.330.630.180.950.15--
Diluted EPS2.86--0.330.630.180.95----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2025Q2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(4.37)(2.43)(2.85)(3.06)(11.36)(16.92)
Capital Expenditures--------0.000.01
Free Cash Flow*--------(11.37)(16.92)
Investing Cash Flow(4.80)(4.80)1.822.0610.460.53
Financing Cash Flow7.847.55------17.37
← Scroll for more columns →

* Derived from reported values